Skip to main content
. Author manuscript; available in PMC: 2009 Nov 15.
Published in final edited form as: Prostate. 2009 May 15;69(7):719–726. doi: 10.1002/pros.20922

Table 1.

Patient characteristics

Placebo Isoflavone
Total 8 11
Age Mean ± SD 60.8 ± 7.7 55.9 ± 9.5
PSA Mean ± SD 7.4 ± 3.9 5.2 ± 2.3
cT
T1c 4 7
T2a 3 4
T2b 1
pT
T2a 1 1
T2b 3 9
T2c 1
T3a 2
T3b 2
Gleason
3+3 2 1
3+4 1 10
4+3 1
4+5 4
R
R0 6 10
R1 2 1

PSA = Prostate-specific antigen

TNM classification: cT = clinical tumor category, pT = surgical-pathological tumor category, R = residual tumor